Atanas G. Atanasov
Atanas G. Atanasov
Principal Investigator of LBI-DHPS. Editor-in-Chief of #CRBIOTECH. Leader of #DHPSP and #INPST.
Verified email at meduniwien.ac.at - Homepage
Title
Cited by
Cited by
Year
Discovery and resupply of pharmacologically active plant-derived natural products: A review
AG Atanasov, B Waltenberger, EM Pferschy-Wenzig, T Linder, ...
Biotechnology advances 33 (8), 1582-1614, 2015
11832015
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
L Wang, B Waltenberger, EM Pferschy-Wenzig, M Blunder, X Liu, ...
Biochemical pharmacology 92 (1), 73-89, 2014
4422014
Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase
AG Atanasov, LG Nashev, RAS Schweizer, C Frick, A Odermatt
FEBS letters 571 (1-3), 129-133, 2004
2352004
Ethnopharmacological in vitro studies on Austria's folk medicine—An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs
S Vogl, P Picker, J Mihaly-Bison, N Fakhrudin, AG Atanasov, EH Heiss, ...
Journal of Ethnopharmacology 149 (3), 750-771, 2013
2202013
Inflammatory markers for arterial stiffness in cardiovascular diseases
I Mozos, C Malainer, J Horbańczuk, C Gug, D Stoian, CT Luca, ...
Frontiers in immunology 8, 1058, 2017
1422017
Activated AMPK boosts the Nrf2/HO-1 signaling axis—a role for the unfolded protein response
K Zimmermann, J Baldinger, B Mayerhofer, AG Atanasov, VM Dirsch, ...
Free Radical Biology and Medicine 88, 417-426, 2015
1282015
A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity
RAS Schweizer, AG Atanasov, BM Frey, A Odermatt
Molecular and cellular endocrinology 212 (1-2), 41-49, 2003
1282003
Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications
M Uddin, A Stachowiak, AA Mamun, NT Tzvetkov, S Takeda, AG Atanasov, ...
Frontiers in Aging Neuroscience 10, 4, 2018
1222018
Honokiol: a non-adipogenic PPARγ agonist from nature
AG Atanasov, JN Wang, SP Gu, J Bu, MP Kramer, L Baumgartner, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4813-4819, 2013
1152013
A critical analysis of extraction techniques used for botanicals: Trends, priorities, industrial uses and optimization strategies
T Belwal, SM Ezzat, L Rastrelli, ID Bhatt, M Daglia, A Baldi, HP Devkota, ...
TrAC Trends in Analytical Chemistry 100, 82-102, 2018
1102018
The role of nutraceuticals in statin intolerant patients
M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ...
Journal of the American College of Cardiology 72 (1), 96-118, 2018
1032018
Natural products to counteract the epidemic of cardiovascular and metabolic disorders
B Waltenberger, A Mocan, K Šmejkal, EH Heiss, AG Atanasov
Molecules 21 (6), 807, 2016
902016
Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen?: Physiological relevance of the membrane topology of 11β-HSD1
A Odermatt, AG Atanasov, Z Balazs, RAS Schweizer, LG Nashev, ...
Molecular and cellular endocrinology 248 (1-2), 15-23, 2006
872006
Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates
AG Atanasov, S Tam, JM Röcken, ME Baker, A Odermatt
Biochemical and biophysical research communications 308 (2), 257-262, 2003
852003
Organotins disrupt the 11β-hydroxysteroid dehydrogenase type 2–dependent local inactivation of glucocorticoids
AG Atanasov, LG Nashev, S Tam, ME Baker, A Odermatt
Environmental health perspectives 113 (11), 1600-1606, 2005
812005
Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance
A Odermatt, C Gumy, AG Atanasov, AA Dzyakanchuk
The Journal of steroid biochemistry and molecular biology 102 (1-5), 222-231, 2006
802006
Direct protein–protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen
AG Atanasov, LG Nashev, L Gelman, B Legeza, R Sack, R Portmann, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1783 (8), 1536-1543, 2008
742008
Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor γ
N Fakhrudin, A Ladurner, AG Atanasov, EH Heiss, L Baumgartner, ...
Molecular pharmacology 77 (4), 559-566, 2010
722010
NF-κB Inhibitors from Eurycoma longifolia
TVA Tran, C Malainer, S Schwaiger, AG Atanasov, EH Heiss, VM Dirsch, ...
Journal of natural products 77 (3), 483-488, 2014
672014
Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
D Tewari, SF Nabavi, SM Nabavi, A Sureda, AA Farooqi, AG Atanasov, ...
Pharmacological Research 128, 366-375, 2018
662018
The system can't perform the operation now. Try again later.
Articles 1–20